类风湿关节炎中循环脂肪因子及其与新发心血管疾病的关联
研究纳入2598例类风湿关节炎患者,检测基线血清脂联素、瘦素和成纤维细胞生长因子21水平并按中位数二分类,随访19585人年,采用多变量Cox模型分析脂肪因子与新发心血管事件的关联。高脂联素与心衰住院和心血管病相关死亡独立相关,高瘦素与心血管病相关死亡独立相关,高FGF-21与较低冠心病风险独立相关;非肥胖患者中关联更强。
要点
- 高脂联素与心衰住院(HR 1.39)和心血管病相关死亡(HR 1.49)独立相关。
- 高瘦素与心血管病相关死亡独立相关(HR 1.44)。
- 高FGF-21与较低冠心病风险独立相关(HR 0.75)。
核心结论
- 脂肪因子与类风湿关节炎患者的心衰住院和心血管病相关死亡相关,在非肥胖参与者中关联更强。
- 这些发现提示脂肪因子可能有效预测类风湿关节炎中具有临床意义的结果,或许通过体成分和代谢健康的关联实现。
- 需要进一步研究以确定脂肪因子检测是否能增强现有工具来识别心血管疾病风险升高的类风湿关节炎患者。
研究设计与样本
- 研究采用类风湿关节炎患者入库 enrollment 血清检测脂联素、瘦素和成纤维细胞生长因子21(FGF-21),并按中位数二分类为高/低水平。
- 新发心血管疾病事件(冠心病、卒中、心衰住院、静脉血栓栓塞、心血管病相关死亡)通过行政数据和美国国家死亡指数识别。
- 协变量来自病历、生物样本库和登记数据库,采用多变量Cox模型量化脂肪因子浓度与心血管疾病发病率的关联,并预测5年发病率。
主要发现
- 在2598例参与者中,639例(25%)在19585人年随访期间发生至少1次心血管疾病事件。
- 高脂联素水平与心衰住院独立相关(HR 1.39 [95% CI 1.07-1.79],P = 0.01),与心血管病相关死亡独立相关(HR 1.49 [95% CI 1.16-1.92],P = 0.002),与其他心血管事件无独立关联。
- 高瘦素与心血管病相关死亡独立相关(HR 1.44 [95% CI 1.05-1.97],P = 0.02)。
- 高FGF-21水平与较低冠心病发病率独立相关(HR 0.75 [95% CI 0.58-0.97],P = 0.03)。
- 亚组分析中,高脂联素和高瘦素与心血管病相关死亡的关联由非肥胖患者中的强关联驱动。
临床怎么用
- 原文结论未据此给出推荐。
局限性
- 需要进一步研究以确定脂肪因子检测是否能增强现有工具来识别心血管疾病风险升高的类风湿关节炎患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether circulating levels of adiponectin, leptin, and fibroblast growth factor 21 (FGF-21) are associated with incident cardiovascular disease (CVD) in rheumatoid arthritis (RA). METHODS: Adipokines were measured using banked enrollment serum from patients with RA and dichotomized above/below the median value. Incident CVD events (coronary artery disease [CAD], stroke, heart failure [HF] hospitalization, venous thromboembolism, CVD-related deaths) were identified using administrative data and the National Death Index. Covariates were derived from medical record, biorepository, and registry databases. Multivariable Cox models were generated to quantify associations between adipokine concentrations and CVD incidence. Five-year incidence rates were predicted. RESULTS: Among 2,598 participants, 639 (25%) had at least 1 CVD event over 19,585 patient-years of follow-up. High adiponectin levels were independently associated with HF hospitalization (hazard ratio [HR] 1.39 [95% confidence interval (95% CI) 1.07-1.79], P = 0.01) and CVD-related death (HR 1.49 [95% CI 1.16-1.92], P = 0.002) but not with other CVD events. High leptin was independently associated with CVD-related death (HR 1.44 [95% CI 1.05-1.97], P = 0.02). High FGF-21 levels were independently associated with lower rates of CAD (HR 0.75 [95% CI 0.58-0.97], P = 0.03). In subgroup analyses, associations between high adiponectin and leptin levels with CVD-related death were driven by strong associations in nonobese patients. CONCLUSION: Adipokines are associated with HF hospitalization and CVD-related death in patients with RA, with stronger associations in nonobese participants. These findings suggest that adipokines effectively predict clinically important outcomes in RA perhaps through an association with body composition and metabolic health. Further study is needed to determine whether adipokine measures might augment existing tools to identify RA patients at increased risk of CVD.
引用
- Federico LE, Johnson TM, England BR, et al. Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2022. PMID: 35313088. doi:10.1002/acr.24885
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。